Synapse - A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies

A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies Meeting Abstract

Authors:	Boulad, F.; Jakubowski, A.; Castro-Malaspina, H.; Hsu, K. C.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; Young, J. W.; Ro, M.; Collins, N.; O'Reilly, R. J.
Abstract Title:	A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies
Meeting Title:	46th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	104
Issue:	11 Pt. 1
Meeting Dates:	2004 Dec 4-7
Meeting Location:	San Diego, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2004-11-16
Start Page:	504A
End Page:	505A
Language:	English
ACCESSION:	WOS:000225127501823
PROVIDER:	wos
PUBMED:	15562524
DOI:	10.1182/blood.V104.11.1822.1822
Notes:	Meeting Abstract: 1822 -- 46th Annual Meeting of the American-Society-of-Hematology -- DEC 04-07, 2004 -- San Diego, CA -- 1 -- Source: Wos